Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Bioheart, Inc. (BHRT) Announces Addition Of Frank Young As Financial Consultant 0 comments
    Jan 31, 2012 10:21 AM | about stocks: BHRT
    Located in SUNRISE, Florida, Bioheart is committed to developing stem cell therapies to treat congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions, and other medical problems. Yesterday, Bioheart took a major step towards prominence with the announcement that industry-veteran Frank Young has joined their company as a financial consultant.

    Young brings with him more than 30 years of experience launching and managing venture-backed companies in the technology and healthcare industries, and he has served as the young company's CFO from 2003 to 2005.

    Earlier in his career, Young worked as CFO with CURNA, a healthcare company known for its discovery of new therapeutic compounds. He engineered the sale of the company in fewer than two years for more than five times the invested capital. He also worked as CFO with Mitral Solutions and Hyperion. As CFO with Bioheart, Young assisted in raising more than $9.5 million from investors in addition to negotiating international manufacturing arrangements and joint ventures.

    Leading the way at Bioheart is Mike Tomas whom serves as the company's President and CEO. In reference to this press release, Tomas stated, "Frank's entrepreneurial spirit and successful fundraising strategies, combined with his previous accomplishments at Bioheart, make him an ideal fit for Bioheart. Frank has a proven track record launching, managing and financially advising numerous companies across the healthcare industry."

    When asked his thoughts on the new position, Young stated, "I look forward to becoming an integral part of Bioheart's financial future as it continues to develop life-saving technologies for victims of heart disease."

    Currently, Bioheart is trading in the $0.04 range. To learn more about the company as a whole, visit their corporate website at bioheartinc.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: BHRT
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.